AAMDSIF sponsors live education events throughout the year. This includes satellite symposia at annual medical association meetings, as well as smaller live regional events where community-based health professionals can hear from leading experts. The International Bone Marrow Failure Disease Scientific Symposium is our biennial professional meeting held near Washington, DC.
BMT and Immunotherapies for Pediatric Leukemia
Current and novel treatments and financial implications
Jointly planned by the National Marrow Donor Program®/Be The Match® and the Aplastic Anemia and MDS International Foundation.
Bone marrow transplant (BMT) and immunotherapies continue to quickly evolve for pediatric leukemia, varying in the pathophysiology and management. For health professionals, knowledge of these treatment options and potential toxicities is necessary to manage and provide patients with safe and effective evidence-based care. When choosing these treatment options, families can face additional financial decisions and need assistance to manage the financial implications.
View program slides here!
ONS 2018 Satellite Symposium Enduring Program
This symposium was recorded at the ONS 43rd Annual Congress in Washington, DC on May 17, 2018. The program focuses on recent advances in diagnosing and treating myelodysplastic syndromes and related diseases, including AML and MDS/MPN overlap, and the role of nurses in disease management and care coordination. Case studies are used to illustrate treatment decision-making and therapeutic challenges.
- Explain the role of genetic testing and precision medicine in diagnosing and treating bone marrow failure diseases;
- Identify emerging treatment options for patients with MDS, AML, MDS/MPN overlap and other bone marrow failure diseases;
- Analyze the nurse's role in managing treatment for bone marrow failure diseases based on clinical presentations, comorbidities and diagnostic workups;
- Discuss the nurse's role in collaboration with other disciplines in addressing quality of life issues and providing patient education to improve outcomes.
Nancy Corbitt, BSN, RN, OCN, CRNI , University of Maryland Greenebaum Cancer Center, Baltimore, MD
- Katherine Edmonds, MSN, ANRP-C, Dana-Farber Cancer Institute, Boston, MA
- Lisa Barbarotta, MSN, APRN-BC, AOCNS, Smilow Cancer Hospital, Yale Medical Center, New Haven, CT
- Kelly Fields Owens , LMSW, Vanderbilt University Medical Center, Nashville, TN
This activity is jointly provided by Medical Learning Institute, Inc. and the Aplastic Anemia and MDS International Foundation.
This activity is supported by an educational grant from Celgene Corporation.
This activity was developed for nurses and nurse practitioners who are involved in the treatment or management of patients with bone marrow failure disease.
Nursing Education Purpose Statement
The purpose of this activity is to improve the knowledge and competence of nurses concerning the treatment or management of patients with bone marrow failure disease.
Registered Nurse Designation
Medical Learning Institute, Inc.
Provider approved by California Board of Registered Nursing, Provider Number 15106, for 1.5 contact hours.
Nurse Practitioner Credit Designation
This activity is approved for 1.5 contact hour(s) of continuing education (which includes 1.5 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 18063240. This activity was planned in accordance with AANP Accreditation Standards and Policies.